coronary microvascular disease
Conditions
Interventions
Exposure group:Shexiang Tongxin Dropping Pill+Standardized treatment
Non-exposure group :Standardized treatment
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18 and 80 years (inclusive) with no gender restrictions; (2) Meet the diagnostic criteria for Angina with Non-Obstructive Coronary Arteries (ANOCA); (3) The patient voluntarily participates in the study and agrees to follow-up.
Exclusion criteria
Exclusion criteria: (1) Individuals allergic to any component in Shexiang Tongxin Dropping Pill or any ingredient in the medication; (2) Pregnant women or women planning to become pregnant; (3) Patients with malignant tumors severe valvular heart disease or malignant arrhythmias; (4) Individuals who have taken or are currently taking traditional Chinese medicines of the same category as Musk Heart-Dropping Pill within the past month; (5) Individuals who have participated in or are currently participating in other clinical trials within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle Angina Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Generalized Anxiety Disorder-7;Incremental Cost-Effectiveness Ratio;9-item Depression Module of the Patient Health Questionnaire;major adverse cardiac events;Diagnostic Scoring of Syndrome Elements for Angina Pectoris in Coronary Heart Disease; | — |
Countries
China
Contacts
Public ContactLei Wang
Guangdong Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed